[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":55450000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":204826000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":100000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-182000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":15183000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-86837000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":267000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":323977000.0,"InvestmentsFairValueDisclosure_0_Q1_USD":490855000.0,"OtherAssetsNoncurrent_0_Q1_USD":6348000.0,"PrepaidExpenseCurrent_0_Q1_USD":5884000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":2832000.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":9692879.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":3437000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":6909000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1154000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":15183000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":408000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":496521.0,"PaymentsToAcquireInvestments_1_Q1_USD":230384000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":4365000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":108381000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":400000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"InterestReceivableCurrent_0_Q1_USD":1959000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":331000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":157970000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":204505000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":21567000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":490855000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":696000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":878000.0,"AssetsFairValueDisclosure_0_Q1_USD":695360000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":21567000.0,"MarketableSecuritiesCurrent_0_Q1_USD":490855000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":520000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1174000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":490673000.0,"ShareBasedCompensation_1_Q1_USD":21567000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":71708000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesCurrent_0_Q1_USD":56047000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":713447000.0,"Liabilities_0_Q1_USD":57221000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":18046000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.02,"Depreciation_1_Q1_USD":126000.0,"CommonStockValue_0_Q1_USD":44000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":339201000.0,"CommonStockSharesOutstanding_0_Q1_shares":43552312.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":204505000.0,"AssetsCurrent_0_Q1_USD":704816000.0,"Assets_0_Q1_USD":713447000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":11867124.0,"AdditionalPaidInCapital_0_Q1_USD":1505431000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":9707000.0,"AccountsPayableCurrent_0_Q1_USD":9587000.0,"CommonStockSharesIssued_0_Q1_shares":43552312.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-122227000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-59004000.0,"NetIncomeLoss_1_Q1_USD":-86655000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-89487000.0,"OperatingExpenses_1_Q1_USD":89754000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":42886691.0,"StockholdersEquity_0_Q1_USD":656226000.0,"Revenues_1_Q1_USD":267000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-858956000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2283000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":323977000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":9456000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":224000.0,"RestrictedCash_0_Q1_USD":321000.0,"RestrictedCashNoncurrent_0_Q1_USD":300000.0,"Ticker":"MRTX","CIK":"1576263","name":"MIRATI THERAPEUTICS, INC.","OfficialName":"Mirati Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4261498445.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]